All 1 tracked stories fall under one category: funding. Oncare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.5. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Sky Impact Capital
All 1 tracked stories fall under one category: funding. Oncare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.5. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Sky Impact Capital appears in 1 tracked Startup story from February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Sky Impact Capital. Shared-story counts are live from our verified record — not editorial picks.
Delhi-based oncology startup Oncare has raised ₹27 crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will fuel the company's expansion from its current Delhi NCR hub into metro, Tier-2, and Tier-3 cities nationwide.
Sky Impact Capital is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.